Vaccine News and Research

Latest Vaccine News and Research

Research on SARS-CoV-2 breakthrough infections shows the danger posed by Delta

Research on SARS-CoV-2 breakthrough infections shows the danger posed by Delta

14 Nov 2021
The case for vaccinating children under 12 against COVID-19

The case for vaccinating children under 12 against COVID-19

14 Nov 2021
Can COVID-19 vaccination lead to neurological complications?

Can COVID-19 vaccination lead to neurological complications?

14 Nov 2021
Increased risk of breakthrough SARS-CoV-2 infection with ChAdOx1 compared to BNT162b2 vaccine

Increased risk of breakthrough SARS-CoV-2 infection with ChAdOx1 compared to BNT162b2 vaccine

14 Nov 2021
Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

14 Nov 2021
Asia Pacific region plans to fall back on traditional medicine post-COVID-19

Asia Pacific region plans to fall back on traditional medicine post-COVID-19

14 Nov 2021
£375 million Government funding to improve treatment for neurodegenerative diseases

£375 million Government funding to improve treatment for neurodegenerative diseases

14 Nov 2021
Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

12 Nov 2021
Rugby figures urge people to get vaccinated and take action to reduce COVID-19 transmission

Rugby figures urge people to get vaccinated and take action to reduce COVID-19 transmission

12 Nov 2021
New findings about naturally acquired immunity may help improve existing malaria vaccines

New findings about naturally acquired immunity may help improve existing malaria vaccines

12 Nov 2021
COVID-19 vaccination humoral immune response in individuals with diabetes

COVID-19 vaccination humoral immune response in individuals with diabetes

12 Nov 2021
Potential remaining COVID-19 burden in European countries

Potential remaining COVID-19 burden in European countries

12 Nov 2021
SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

SARS-CoV-2 self-amplifying mRNA vaccine demonstrates cellular and humoral immune responses

12 Nov 2021
Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

Immune responses with and without previous SARS-CoV-2 infection following single BNT162b2 vaccine dose

12 Nov 2021
Research finds greater mortality risk among rural COVID patients in ICUs than urban counterparts

Research finds greater mortality risk among rural COVID patients in ICUs than urban counterparts

11 Nov 2021
Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

Vaccinated patients hospitalized with COVID-19 in Norway spend fewer days in the hospital

11 Nov 2021
Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds

11 Nov 2021
Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine

Long-term effectiveness of Pfizer/BioNTech two-dose regimen mRNA vaccine

11 Nov 2021
Flu season emerging against the backdrop of COVID-19 pandemic

Flu season emerging against the backdrop of COVID-19 pandemic

11 Nov 2021
More than 11.4 million people in the UK receive COVID-19 booster jabs

More than 11.4 million people in the UK receive COVID-19 booster jabs

11 Nov 2021

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback